AstraZeneca

AZ
Content Channel

FDA delays ruling on AstraZeneca drug after negative adcomm vote

The FDA deferred its ruling on AstraZeneca’s camizestrant to review analyses filed after an advisory committee voted against the breast cancer asset.
Nick Paul Taylor May 27, 2026 4:43am
A doctor with black painted nails types on a sleek keyboard that is next to a stethoscope

AstraZeneca pens agentic AI licensing deal with Owkin

May 13, 2026 2:06am
Palm tree branches bending as storm clouds approach

AstraZeneca’s $800M bet undermined by immunogenicity in phase 3

May 12, 2026 9:28am
Collage poster study of businessmen picture chart arrow goes up
Favicon Fierce Pharma

Daiichi Sankyo targets global top 5 oncology rank by 2035

May 11, 2026 10:22am
AstraZeneca RD robot

From R&D to M&A: Big Pharmas showcase ‘measurable impact’ of AI

May 7, 2026 9:10am
AZ

FDA panel rejects AstraZeneca's novel oral SERD proposal

Apr 30, 2026 1:48pm